Evidence map›Paper›PMID 41371744›Full record

ArticleBMJ open2025

Enablers and barriers for scaling up non-communicable disease interventions across diverse global health contexts: a qualitative study using the Consolidated Framework for Implementation Research.

Zinzi Pardoel, Ilona Folkertsma, Anusha Ramani-Chander, Amanda G Thrift, Rohina Joshi, Isobel Bandurek, Josefien van Olmen, Abha Shrestha, Lal B Rawal, Edwin Wouters and 15 more

Abstract read
In one paragraph

Article in BMJ open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Zinzi PardoelDepartment of Health Sciences, University Medical Center Groningen, University of Groningen, Groningen, Netherlands z.e.pardoel@umcg.nl.ORCID http://orcid.org/0000-0002-6520-2637
Ilona FolkertsmaDepartment of Health Sciences, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.
Anusha Ramani-ChanderDepartment of Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia.ORCID http://orcid.org/0000-0003-2461-7139
Amanda G ThriftMedicine, Monash University Stroke and Ageing Research Group, Clayton, Victoria, Australia.ORCID http://orcid.org/0000-0001-8533-4170
Rohina JoshiSchool of Population Health, University of New South Wales (UNSW), Sydney, New South Wales, Australia.
Isobel BandurekGlobal Alliance for Chronic Diseases, London, UK.
Josefien van OlmenDepartment of Primary and Interdisciplinary Care, University of Antwerp, Antwerp, Belgium.
Abha ShresthaDepartment of Community Medicine, Kathmandu University School of Medical Sciences, Dhulikhel, Nepal.ORCID http://orcid.org/0000-0002-7992-7137
Lal B RawalWestern Sydney University, Sydney, New South Wales, Australia.
Edwin WoutersUniversity of Antwerp, Antwerp, Belgium.ORCID http://orcid.org/0000-0003-2268-3829
Asri MaharaniNursing, Midwifery and Social Care, The University of Manchester, Manchester, UK.ORCID http://orcid.org/0000-0002-5931-8692
Peter DelobelleUniversity of Cape Town, Rondebosch, South Africa.ORCID http://orcid.org/0000-0002-9016-7458
Hueiming LiuThe George Institute for Global Health, Sydney, New South Wales, Australia.ORCID http://orcid.org/0000-0001-9077-8673
Michaela TheilmannFaculty of Medicine, Hillah, Iraq.
Jacqui WebsterThe George Institute for Global Health, Sydney, New South Wales, Australia.
Sujarwoto SujarwotoPublic Administration, Brawijaya University, Malang, Indonesia.ORCID http://orcid.org/0000-0003-4197-4592
Kamran SiddiqiUniversity of York, York, UK.ORCID http://orcid.org/0000-0003-1529-7778
Ari ProbandariPublic Health, Universitas Sebelas Maret, Surakarta, Indonesia.ORCID http://orcid.org/0000-0003-3171-5271
Vitri WidyaningsihFaculty of Medicine Universitas Sebelas Maret, Surakarta, Indonesia.ORCID http://orcid.org/0000-0003-0116-7120
Jaime MirandaThe University of Sydney Faculty of Medicine and Health, Sydney, New South Wales, Australia.ORCID http://orcid.org/0000-0002-4738-5468
Puhong ZhangThe George Institute for Global Health UK, Oxford, UK.ORCID http://orcid.org/0000-0003-4610-9848
Lisa StehrHeidelberg University, Heidelberg, Germany.
Lisa R HirschhornMedical Social Sciences, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.ORCID http://orcid.org/0000-0002-4355-7437
Jaap KootDepartment of Health Sciences, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.ORCID http://orcid.org/0000-0002-6933-0302
Manna AlmaDepartment of Health Sciences, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo identify enablers and barriers for scaling up non-communicable disease (NCD) interventions across diverse global contexts and to map these factors to the WHO's health system building blocks.

designA multi-method qualitative study applying the Consolidated Framework for Implementation Research to analyse data from multiple projects nearing or completing scale-up.

settingGlobal Alliance for Chronic Diseases-funded implementation research projects conducted across 18 low- and middle-income countries and high-income settings.

participantsData was derived from documents (n=77) including peer-reviewed publications, policy briefs, and reports and interviews with stakeholders (n=18) (eg, principal investigators, medical professionals, public health workers).

interventionsVarious context-specific interventions targeting sustainable scale-up of NCD (eg, diabetes, hypertension, cardiovascular disease) interventions at the community, primary care or policy levels. PRIMARY AND SECONDARY OUTCOME MEASURES: The primary outcome was identifying contextual enablers and barriers to intervention scale-up. Secondary outcomes included exploring how these factors aligned with health system building blocks (eg, leadership/governance, healthcare workforce).

resultsTwenty enablers (eg, intervention adaptability, strong stakeholder engagement, local empowerment) and 25 barriers (eg, resource limitations, intervention complexity, stakeholder burnout) were identified. Contextual alignment, supportive governance and capacity building were critical for sustainability, while cultural misalignment and socio-political instability frequently hampered scaling efforts.

conclusionsTailoring interventions to local health systems, ensuring stakeholder co-ownership and incorporating strategies to mitigate stakeholder burn-out are essential to achieving sustainable, scalable NCD solutions. Future research should focus on integrating systematic cultural adaptation, sustainable financing and workforce capacity building into scale-up planning.

Indexed as

Global HealthNoncommunicable DiseasesHealth PolicyHumansQualitative ResearchCardiovascular DiseaseChronic DiseaseDiabetes Mellitus, Type 2HypertensionImplementation Science

Identifiers

PMID41371744
PMCPMC12699587

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.